- Schizophrenia Patients Find Hope in First New Drugs in Decades Bloomberg
- As Bristol Myers’ schizophrenia drug nears approval, AbbVie and others hope to provide competition BioPharma Dive
- Regulators Expected To Approve Innovative Schizophrenia Treatment From Bristol Myers, Karuna Benzinga
[ad_2]
Source link
